Filing Flows › AbbVie (ABBV) › Q1 2025
AbbVie (ABBV) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 9, 2025
AbbVie (ABBV) reported revenue of $13.3B for the first quarter 2025 (Q1 2025), +8% from a year earlier and -12% from the quarter before. Operating margin was 28.0%, net earnings $1.3B (9.7% of revenue).
AbbVie, Q1 2025: revenue $13.3B (+8% year over year), operating margin 28.0%, net earnings $1.3B, operating cash flow $1.6B. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.3B | -12% | +8% |
| Operating profit | $3.7B | — | +33% |
| Net earnings | $1.3B | — | -6% |
| Operating cash flow | $1.6B | -77% | -60% |
| Free cash flow | $1.4B | -79% | -64% |
What changed
Revenue was $13.3B in Q1 2025, up 8% year over year and down 12% from the previous quarter.
Operating profit was $3.7B, a 28.0% margin (up 5.2 points year over year). Of the extra revenue versus a year earlier, 91% reached operating profit, above the 23% margin then. Total costs grew 1% against revenue growth of 8%. The fastest-growing cost line was Other operating costs (+51%). Net earnings were $1.3B, down 6% year over year. The effective tax rate was 22.4%.
Operating cash flow was $1.6B (down 60% year over year), 127% of net earnings. Non-cash charges added back $2.0B of depreciation and amortization and $0.41B of share-based compensation. Working capital and other items used $2.1B. Capital expenditures of $0.23B left free cash flow of $1.4B.
Questions
What was AbbVie's revenue in the first quarter 2025?
AbbVie (ABBV) reported revenue of $13.3B for the first quarter 2025 (Q1 2025), +8% from a year earlier and -12% from the quarter before.
Was AbbVie profitable in the first quarter 2025?
Operating profit was $3.7B (28.0% of revenue) and net earnings $1.3B.
Source: AbbVie 10-Q on SEC EDGAR.